BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30904277)

  • 21. [Bullous drug reactions].
    Hertl-Yazdi MS; Hertl M
    Hautarzt; 2005 Jan; 56(1):16-23. PubMed ID: 15625601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed-type allergy to oral nimodipine.
    Nucera E; Schavino D; Roncallo C; de Pasquale T; Buonomo A; Pollastrini E; Patriarca G
    Contact Dermatitis; 2002 Oct; 47(4):246-7. PubMed ID: 12492537
    [No Abstract]   [Full Text] [Related]  

  • 23. Postoperative rash to ceftriaxone.
    San Miguel MM; Gaig P; Bartra J; García-Ortega P
    Allergy; 2000 Oct; 55(10):977-9. PubMed ID: 11030384
    [No Abstract]   [Full Text] [Related]  

  • 24. Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation?
    Jappe U
    Allergy; 2007 Dec; 62(12):1474-5. PubMed ID: 17983386
    [No Abstract]   [Full Text] [Related]  

  • 25. Danger signs in drug hypersensitivity.
    Scherer K; Bircher AJ
    Med Clin North Am; 2010 Jul; 94(4):681-9, xv-x. PubMed ID: 20609857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to the patient with drug allergy.
    Schnyder B
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):405-18. PubMed ID: 19563988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?].
    Absmaier M; Biedermann T; Brockow K
    Hautarzt; 2017 Jan; 68(1):29-35. PubMed ID: 27986978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophilic drug reactions.
    Coromilas AJ; Gallitano SM
    Clin Dermatol; 2020; 38(6):648-659. PubMed ID: 33341199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs].
    Ben Mahmoud L; Bahloul N; Ghozzi H; Kammoun B; Hakim A; Sahnoun Z; Kammoun S; Zeghal K
    Therapie; 2017 Oct; 72(5):539-545. PubMed ID: 28416298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intolerance of fondaparinux in a patient allergic to heparins.
    Hirsch K; Ludwig RJ; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2004 Jun; 50(6):383-4. PubMed ID: 15274739
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypersensitivity to paroxetine.
    Mera MT; Pérez BV; Fernández RO; Iglesias JF
    Allergol Immunopathol (Madr); 2006; 34(3):125-6. PubMed ID: 16858890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoricoxib-induced acute generalized exanthematous pustulosis.
    Mäkelä L; Lammintausta K
    Acta Derm Venereol; 2008; 88(2):200-1. PubMed ID: 18311467
    [No Abstract]   [Full Text] [Related]  

  • 33. Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center.
    Yau P; Jimenez-Zepeda VH; Bailey K; Duggan P; Tay J; Bahlis NJ; Neri P; McCulloch S
    Leuk Lymphoma; 2019 Dec; 60(13):3199-3203. PubMed ID: 31190585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ambulatory oral provocation testing].
    Wüthrich B
    Hautarzt; 1995 May; 46(5):352-3. PubMed ID: 7607902
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug eruptions in geriatric patients.
    Fisher AA
    Cutis; 1976 Sep; 18(3):402-9. PubMed ID: 138570
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and management of HIV drug hypersensitivity.
    Davis CM; Shearer WT
    J Allergy Clin Immunol; 2008 Apr; 121(4):826-832.e5. PubMed ID: 18190954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maculopapular rash due to delayed-type hypersensitivity from bismuth salts.
    Gratacós Gómez AR; Joyanes Romo JB; Meneses Sotomayor JV; González Jimenez OM; Palacios Cañas A; Gómez Torrijos E
    Contact Dermatitis; 2022 Mar; 86(3):228-229. PubMed ID: 34791673
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical practice. Exanthematous drug eruptions.
    Stern RS
    N Engl J Med; 2012 Jun; 366(26):2492-501. PubMed ID: 22738099
    [No Abstract]   [Full Text] [Related]  

  • 39. [Severe delayed drug hypersensitivity reactions].
    Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C
    Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions.
    Poza-Guedes P; González-Pérez R; Canto G
    Contact Dermatitis; 2002 Oct; 47(4):244-5. PubMed ID: 12492535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.